TISIDB revealed five immune subtypes related to gastric cancer; we discovered that PDGFD has higher expression in the TGF-B subtype compared to the other four subtypes, indicating that PDGFD may act as an immunomodulatory factor in the TGF-B subtype (Figure 5(a)). This evidence concerns the gene TGFB1 and gastric cancer.